Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Description

The purpose of the study is to compare the success rates of procedure success and complication rates in patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using two types of currently available endoscopes. These are (1) duodenoscope with a Single-use distal cover or (2) a conventional reusable duodenoscope.

Conditions

Biliary Disease, Pancreatic Disease, Choledocholithiasis, Biliary Obstruction, Biliary Tract Neoplasms, Pancreatic Neoplasms

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the study is to compare the success rates of procedure success and complication rates in patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using two types of currently available endoscopes. These are (1) duodenoscope with a Single-use distal cover or (2) a conventional reusable duodenoscope.

Comparison of Outcomes in Patients Undergoing Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) Using Duodenoscope With Single-use Distal Cover and Conventional Reusable Duodenoscope: A Randomized Controlled Trial

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Condition
Biliary Disease
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford hospital, Palo Alto, California, United States, 943305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients undergoing ERCP for biliary and pancreatic conditions
  • * Age \> 18 years old
  • * Vulnerable patient groups including pregnant women
  • * Patients who are unable to consent
  • * Patients with known cholangitis
  • * Patients with known Carbapenem-Resistant Enterobacteriaceae (CRE) or any other multi-drug resistant organisms (MDRO) infection
  • * Surgically altered anatomy except for Billroth I

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Subhas Banerjee, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2024-12-31